Abstract
Abstract
Machine learning has the potential to identify novel biological factors underlying successful antibody responses to influenza vaccines. The first attempts have revealed a high level of complexity in establishing influenza immunity, and many different cellular and molecular components are involved. Of note is that the previously identified correlates of protection fail to account for the majority of individual responses across different age groups and influenza seasons. Challenges remain from the small sample sizes in most studies and from often limited data sets, such as transcriptomic data. Here we report the creation of a unified database, FluPRINT, to enable large-scale studies exploring the cellular and molecular underpinnings of successful antibody responses to influenza vaccines. Over 3,000 parameters were considered, including serological responses to influenza strains, serum cytokines, cell phenotypes, and cytokine stimulations. FluPRINT, facilitates the application of machine learning algorithms for data mining. The data are publicly available and represent a resource to uncover new markers and mechanisms that are important for influenza vaccine immunogenicity.
Publisher
Springer Science and Business Media LLC
Subject
Library and Information Sciences,Statistics, Probability and Uncertainty,Computer Science Applications,Education,Information Systems,Statistics and Probability
Reference60 articles.
1. Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300 (2018).
2. Food & Drug Administration. Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines,
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-data-needed-support-licensure-seasonal-inactivated-influenza-vaccines
(2007).
3. Zhou, H. et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 54, 1427–1436 (2012).
4. de Jong, J. C. et al. Haemagglutination-inhibiting antibody to influenza virus. Developments in biologicals 115, 63–73 (2003).
5. Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19, 1305–1312 (2013).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献